301267 华厦眼科
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)4.69612.36414.78927.98326.716
总资产报酬率 ROA (%)3.4629.43610.32216.90515.645
投入资产回报率 ROIC (%)3.96710.51311.74321.91323.115

边际利润分析
销售毛利率 (%)45.84049.03248.04846.03842.160
营业利润率 (%)19.89424.25522.49921.26819.263
息税前利润/营业总收入 (%)18.12521.78621.19620.31718.634
净利润/营业总收入 (%)13.33216.88015.74914.80312.783

收益指标分析
经营活动净收益/利润总额(%)100.976101.713106.303105.31692.885
价值变动净收益/利润总额(%)9.76510.2372.2191.5000.503
营业外收支净额/利润总额(%)-14.326-13.939-11.296-11.917-5.365

偿债能力分析
流动比率 (X)4.2034.8755.8471.7051.253
速动比率 (X)4.0174.6685.6481.5451.093
资产负债率 (%)26.23722.51323.84142.58332.860
带息债务/全部投入资本 (%)3.9673.9863.4838.1003.904
股东权益/带息债务 (%)2,083.6502,166.1872,400.087859.5542,390.643
股东权益/负债合计 (%)270.614340.438318.601133.609199.783
利息保障倍数 (X)25.06043.69921.62115.46253.052

营运能力分析
应收账款周转天数 (天)29.53223.25121.33220.03723.444
存货周转天数 (天)34.08832.05730.32525.31123.939